Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yueshan Li

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Leukemia & Lymphoma|December 6, 2021
RIPK1 inhibition enhances the therapeutic efficacy of chidamide in FLT3-ITD positive AML, both <i>in vitro</i> and <i>in vivo</i>Jun Li, Dan Liao, Fujue Wang, et al.
ACS Omega|July 12, 2021
Identification of Components in Citri Sarcodactylis Fructus from Different Origins via UPLC-Q-Exactive Orbitrap/MSKanghui Wang, Jingyuan Tian, Yueshan Li, et al.
Zhong Nan Da Xue Xue Bao. Yi Xue Ban = Journal of Central South University. Medical Sciences|December 16, 2021
Efficacy of mandibular molar distalization by clear aligner treatmentDongxue Wu, Yunshan Zhao, Meng Ma, et al.
Bioorganic & Medicinal Chemistry Letters|May 27, 2021
Discovery of 3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one derivatives as a new class of ROCK inhibitors for the treatment of glaucomaYumeng Sun, Yueshan Li, Zhuang Miao, et al.
Molecular Pharmaceutics|April 10, 2012
Receptor-mediated, tumor-targeted gene delivery using folate-terminated polyrotaxanesYi Zhou, He Wang, Chengxi Wang, et al.
ACS Omega|May 27, 2020
UPLC-Q-Exactive Orbitrap MS Analysis for Identification of Lipophilic Components in Citri Sarcodactylis Fructus from Different Origins in China Using Supercritical CO<sub>2</sub> Fluid Extraction MethodChengxiao Fu, Mengshi Liu, Yueshan Li, et al.
Journal of Medicinal Chemistry|December 30, 2023
From Hit to Lead: Structure-Based Optimization of Novel Selective Inhibitors of Receptor-Interacting Protein Kinase 1 (RIPK1) for the Treatment of Inflammatory DiseasesLiting Zhang, Yueshan Li, Chenyu Tian, et al.
Journal of the American Chemical Society|August 29, 2022
Lanthanide-Nucleotide Coordination Nanoparticles for STING ActivationZichao Luo, Xiuqi Liang, Tao He, et al.
Bioorganic & Medicinal Chemistry Letters|July 12, 2023
Discovery of benzodiazepine derivatives as a new class of covalent inhibitors of SARS-CoV-2 main proteaseFalu Wang, Rui Zeng, Jingxin Qiao, et al.
Journal of Medicinal Chemistry|November 7, 2019
Discovery of 4<i>H</i>-Chromen-4-one Derivatives as a New Class of Selective Rho Kinase (ROCK) Inhibitors, which Showed Potent Activity in ex Vivo Diabetic Retinopathy ModelsLanying Zhao, Yueshan Li, Yujiao Wang, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Leukemia & Lymphoma|December 6, 2021
RIPK1 inhibition enhances the therapeutic efficacy of chidamide in FLT3-ITD positive AML, both <i>in vitro</i> and <i>in vivo</i>Jun Li, Dan Liao, Fujue Wang, et al.
ACS Omega|July 12, 2021
Identification of Components in Citri Sarcodactylis Fructus from Different Origins via UPLC-Q-Exactive Orbitrap/MSKanghui Wang, Jingyuan Tian, Yueshan Li, et al.
Zhong Nan Da Xue Xue Bao. Yi Xue Ban = Journal of Central South University. Medical Sciences|December 16, 2021
Efficacy of mandibular molar distalization by clear aligner treatmentDongxue Wu, Yunshan Zhao, Meng Ma, et al.
Bioorganic & Medicinal Chemistry Letters|May 27, 2021
Discovery of 3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one derivatives as a new class of ROCK inhibitors for the treatment of glaucomaYumeng Sun, Yueshan Li, Zhuang Miao, et al.
Molecular Pharmaceutics|April 10, 2012
Receptor-mediated, tumor-targeted gene delivery using folate-terminated polyrotaxanesYi Zhou, He Wang, Chengxi Wang, et al.
ACS Omega|May 27, 2020
UPLC-Q-Exactive Orbitrap MS Analysis for Identification of Lipophilic Components in Citri Sarcodactylis Fructus from Different Origins in China Using Supercritical CO<sub>2</sub> Fluid Extraction MethodChengxiao Fu, Mengshi Liu, Yueshan Li, et al.
Journal of Medicinal Chemistry|December 30, 2023
From Hit to Lead: Structure-Based Optimization of Novel Selective Inhibitors of Receptor-Interacting Protein Kinase 1 (RIPK1) for the Treatment of Inflammatory DiseasesLiting Zhang, Yueshan Li, Chenyu Tian, et al.
Journal of the American Chemical Society|August 29, 2022
Lanthanide-Nucleotide Coordination Nanoparticles for STING ActivationZichao Luo, Xiuqi Liang, Tao He, et al.
Bioorganic & Medicinal Chemistry Letters|July 12, 2023
Discovery of benzodiazepine derivatives as a new class of covalent inhibitors of SARS-CoV-2 main proteaseFalu Wang, Rui Zeng, Jingxin Qiao, et al.
Journal of Medicinal Chemistry|November 7, 2019
Discovery of 4<i>H</i>-Chromen-4-one Derivatives as a New Class of Selective Rho Kinase (ROCK) Inhibitors, which Showed Potent Activity in ex Vivo Diabetic Retinopathy ModelsLanying Zhao, Yueshan Li, Yujiao Wang, et al.
Pageof 3